[1]
“Secondary Myeloid Leukemia and MDS in Patients Treated for Hodgkin Lymphoma – Experience of the German Hodgkin Lymphoma Study Group (GHSG)”, Hematol Meeting Rep, vol. 2, no. 15, Jun. 2009, doi: 10.4081/hmr.v2i15.605.